Compare GSK plc (GSK) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Home Depot Inc — how do they compare? GSK plc trades at $52.7 (market cap $101.34B), while Home Depot Inc trades at $346.04 (market cap $340.46B). The key difference: Home Depot Inc is far larger — about 3.4× GSK plc's market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | HD | |
|---|---|---|
Market Cap | $101.34B | $340.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $61.18 | $423.42 |
52-Week Low | $36.20 | $297.51 |
Enterprise Value | $121.95B | $402.01B |
Dividend Yield | 3.49% | 2.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Home Depot (HD) trades at $347.47, up 2.88% on the day, showing resilience amid mixed earnings performance. The stock exhibits bullish technical signals with strong moving average support, while fundamentals reveal robust revenue growth to $159.51B in 2025 and healthy profitability with 8.41% net margin. Recent institutional activity shows both accumulation and distribution, reflecting divided sentiment ahead of the upcoming Q2 2026 earnings report with expected EPS of $4.71.
The outlook remains cautiously optimistic with a consensus price target of $370.59 offering 6.6% upside potential. Key opportunities include Pro business growth and housing market tailwinds, while risks center on weakening big-ticket demand, margin pressure from investments, and sensitivity to rising mortgage rates affecting home improvement spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
